Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide + formoterol fixed-combination study in persistent asthma
2004-001838-16Phase 2Completed
- Sponsor
- Altana Pharma
- Start
- Sep 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclesonide and formoterol in persistent asthma (5 arms), sponsored by Altana Pharma. Primary endpoint: Primary efficacy variable for morning administration comparison. Started Sep 2004; status: completed.
02
Drugs
ciclesonideformoterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2004-001838-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001838-16.